Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24


Characterization of plasmids harboring blaCTX-M genes in Escherichia coli from French pigs.

Lucas P, Jouy E, Le Devendec L, de Boisséson C, Perrin-Guyomard A, Jové T, Blanchard Y, Touzain F, Kempf I.

Vet Microbiol. 2018 Oct;224:100-106. doi: 10.1016/j.vetmic.2018.08.005. Epub 2018 Aug 4.


Multiplex PCR for detection of plasmid-mediated colistin resistance determinants, mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 for surveillance purposes.

Rebelo AR, Bortolaia V, Kjeldgaard JS, Pedersen SK, Leekitcharoenphon P, Hansen IM, Guerra B, Malorny B, Borowiak M, Hammerl JA, Battisti A, Franco A, Alba P, Perrin-Guyomard A, Granier SA, De Frutos Escobar C, Malhotra-Kumar S, Villa L, Carattoli A, Hendriksen RS.

Euro Surveill. 2018 Feb;23(6). doi: 10.2807/1560-7917.ES.2018.23.6.17-00672. Erratum in: Euro Surveill. 2018 Feb;23(7):.


Characterization of plasmids harboring blaCTX-M and blaCMY genes in E. coli from French broilers.

Touzain F, Le Devendec L, de Boisséson C, Baron S, Jouy E, Perrin-Guyomard A, Blanchard Y, Kempf I.

PLoS One. 2018 Jan 23;13(1):e0188768. doi: 10.1371/journal.pone.0188768. eCollection 2018.


Lack of experimental evidence to support mcr-1-positive Escherichia coli strain selection during oral administration of colistin at recommended and higher dose given by gavage in weaned piglets.

Viel A, Henri J, Perrin-Guyomard A, Laroche J, Couet W, Grégoire N, Laurentie M.

Int J Antimicrob Agents. 2018 Jan;51(1):128-131. doi: 10.1016/j.ijantimicag.2017.04.013. Epub 2017 Jun 28.


Prevalence of mcr-1 in commensal Escherichia coli from French livestock, 2007 to 2014.

Perrin-Guyomard A, Bruneau M, Houée P, Deleurme K, Legrandois P, Poirier C, Soumet C, Sanders P.

Euro Surveill. 2016;21(6). doi: 10.2807/1560-7917.ES.2016.21.6.30135.


Risk Assessment of Deoxynivalenol by Revisiting Its Bioavailability in Pig and Rat Models to Establish Which Is More Suitable.

Saint-Cyr MJ, Perrin-Guyomard A, Manceau J, Houée P, Delmas JM, Rolland JG, Laurentie M.

Toxins (Basel). 2015 Dec 1;7(12):5167-81. doi: 10.3390/toxins7124873.


Use of accuracy profile procedure to validate a real-time PCR method to quantify bacteria in feces.

Saint-Cyr MJ, Perrin-Guyomard A, Houée P, Vasseur MV, Laurentie M.

J AOAC Int. 2014 Mar-Apr;97(2):573-9.


Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora.

Vasseur MV, Laurentie M, Rolland JG, Perrin-Guyomard A, Henri J, Ferran AA, Toutain PL, Bousquet-Mélou A.

Antimicrob Agents Chemother. 2014;58(3):1744-8. doi: 10.1128/AAC.02135-13. Epub 2014 Jan 6.


Evaluation of an oral subchronic exposure of deoxynivalenol on the composition of human gut microbiota in a model of human microbiota-associated rats.

Saint-Cyr MJ, Perrin-Guyomard A, Houée P, Rolland JG, Laurentie M.

PLoS One. 2013 Nov 18;8(11):e80578. doi: 10.1371/journal.pone.0080578. eCollection 2013.


Effect of in-feed paromomycin supplementation on antimicrobial resistance of enteric bacteria in turkeys.

Kempf I, Le Roux A, Perrin-Guyomard A, Mourand G, Le Devendec L, Bougeard S, Richez P, Le Pottier G, Eterradossi N.

Vet J. 2013 Nov;198(2):398-403. doi: 10.1016/j.tvjl.2013.05.030. Epub 2013 Jun 22.


Establishing streptomycin epidemiological cut-off values for Salmonella and Escherichia coli.

Garcia-Migura L, Sunde M, Karlsmose S, Veldman K, Schroeter A, Guerra B, Granier SA, Perrin-Guyomard A, Gicquel-Bruneau M, Franco A, Englund S, Teale C, Heiska H, Clemente L, Boerlin P, Moreno MA, Daignault D, Mevius D, Hendriksen RS, Aarestrup FM.

Microb Drug Resist. 2012 Feb;18(1):88-93. doi: 10.1089/mdr.2011.0064. Epub 2011 Jul 12.


International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries.

Veldman K, Cavaco LM, Mevius D, Battisti A, Franco A, Botteldoorn N, Bruneau M, Perrin-Guyomard A, Cerny T, De Frutos Escobar C, Guerra B, Schroeter A, Gutierrez M, Hopkins K, Myllyniemi AL, Sunde M, Wasyl D, Aarestrup FM.

J Antimicrob Chemother. 2011 Jun;66(6):1278-86. doi: 10.1093/jac/dkr084. Epub 2011 Mar 9.


Emergence of resistant Klebsiella pneumoniae in the intestinal tract during successful treatment of Klebsiella pneumoniae lung infection in rats.

Kesteman AS, Perrin-Guyomard A, Laurentie M, Sanders P, Toutain PL, Bousquet-Mélou A.

Antimicrob Agents Chemother. 2010 Jul;54(7):2960-4. doi: 10.1128/AAC.01612-09. Epub 2010 May 10.


Transfer of plasmid-mediated CTX-M-9 from Salmonella enterica serotype Virchow to Enterobacteriaceae in human flora-associated rats treated with cefixime.

Faure S, Perrin-Guyomard A, Delmas JM, Chatre P, Laurentie M.

Antimicrob Agents Chemother. 2010 Jan;54(1):164-9. doi: 10.1128/AAC.00310-09. Epub 2009 Nov 9.


Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.

Kesteman AS, Ferran AA, Perrin-Guyomard A, Laurentie M, Sanders P, Toutain PL, Bousquet-Mélou A.

Antimicrob Agents Chemother. 2009 Nov;53(11):4740-8. doi: 10.1128/AAC.00608-09. Epub 2009 Sep 8.


Impact of therapeutic treatment with beta-lactam on transfer of the bla(CTX-M-9) resistance gene from Salmonella enterica serovar Virchow to Escherichia coli in gnotobiotic rats.

Faure S, Perrin-Guyomard A, Delmas JM, Laurentie M.

Appl Environ Microbiol. 2009 Sep;75(17):5523-8. doi: 10.1128/AEM.00020-09. Epub 2009 Jul 6.


MLST typing of Escherichia coli isolates overproducing AmpC {beta}-lactamase.

Guillouzouic A, Caroff N, Dauvergne S, Lepelletier D, Perrin Guyomard A, Kempf I, Reynaud A, Corvec S.

J Antimicrob Chemother. 2009 Jun;63(6):1290-2. doi: 10.1093/jac/dkp099. Epub 2009 Mar 22. No abstract available.


Prevalence of high-level vancomycin-resistant enterococci in French broilers and pigs.

Kempf I, Hellard G, Perrin-Guyomard A, Gicquel-Bruneau M, Sanders P, Leclercq R.

Int J Antimicrob Agents. 2008 Nov;32(5):463-4. doi: 10.1016/j.ijantimicag.2008.04.029. Epub 2008 Aug 13. No abstract available.


Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model.

Perrin-Guyomard A, Poul JM, Laurentie M, Sanders P, Fernández AH, Bartholomew M.

Regul Toxicol Pharmacol. 2006 Jun;45(1):66-78. Epub 2006 Mar 24.


Use of avilamycin for growth promotion and avilamycin-resistance among Enterococcus faecium from broilers in a matched case-control study in France.

Chauvin C, Gicquel-Bruneau M, Perrin-Guyomard A, Humbert F, Salvat G, Guillemot D, Sanders P.

Prev Vet Med. 2005 Sep 12;70(3-4):155-63. Epub 2005 Apr 25.


Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model.

Perrin-Guyomard A, Poul JM, Corpet DE, Sanders P, Fernández AH, Bartholomew M.

Regul Toxicol Pharmacol. 2005 Jul;42(2):151-60.


Combined antimicrobial resistance in Enterococcus faecium isolated from chickens.

Petsaris O, Miszczak F, Gicquel-Bruneau M, Perrin-Guyomard A, Humbert F, Sanders P, Leclercq R.

Appl Environ Microbiol. 2005 May;71(5):2796-9.


Antibiotic susceptibility of bacteria isolated from pasteurized milk and characterization of macrolide-lincosamide-streptogramin resistance genes.

Perrin-Guyomard A, Soumet C, Leclercq R, Doucet-Populaire F, Sanders P.

J Food Prot. 2005 Feb;68(2):347-52.


Evaluation of residual and therapeutic doses of tetracycline in the human-flora-associated (HFA) mice model.

Perrin-Guyomard A, Cottin S, Corpet DE, Boisseau J, Poul JM.

Regul Toxicol Pharmacol. 2001 Oct;34(2):125-36.


Supplemental Content

Loading ...
Support Center